Michael Myers - 23 Dec 2024 SCHEDULE 13D Report for Quoin Pharmaceuticals Ltd. Ordinary Shares, no par value per share (represented by American Depositary Shares) (QNRX)

Filing Manager: Michael Myers
Reporting Manager: Michael Myers
Security: Quoin Pharmaceuticals Ltd. Ordinary Shares, no par value per share (represented by American Depositary Shares)
Symbol: QNRX
Shares outstanding: 9,022,797 shares
Disclosed Ownership: 622,573 shares
Ownership: 6.9%
Form type: SCHEDULE 13D
Filing time: 02 Jan 2025, 17:20:09 UTC
Date of event: 23 Dec 2024
Next filing: 28 Jan 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Michael Myers	6.9%	622,573	622,573	0	/s/ Michael Myers	Dr. Michael Myers	0001959547